Medios AG | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
Medios AG

PRESS RELEASE

published on 08/05/2024 at 10:32, 8 months 8 days ago

Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President
Medios AG strengthens activities in Advanced Therapies field, appoints Dr. Andreas Schmiede as Vice President. Focus on personalized medicine innovations and patient access to cutting-edge therapies

Medios AG Advanced Therapies Personalized Medicine Dr. Andreas Schmiede Pharmaceutical Innovations
BRIEF

published on 07/01/2024 at 09:37, 9 months 12 days ago

« Hauptstadtkongress 2024 » : Medios organise un symposium sur la « sécurité d'approvisionnement »

Medios AG Pharmacie Spécialisée Congrès De La Hauptstadt 2024 Système De Soins De Santé Sécurité D'approvisionnement
BRIEF

published on 07/01/2024 at 09:37, 9 months 12 days ago

“Hauptstadtkongress 2024”: Medios Hosts Symposium on 'Security of Supply'

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
PRESS RELEASE

published on 07/01/2024 at 09:32, 9 months 12 days ago

“Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply”
Medios AG participated in 'Hauptstadtkongress 2024', focusing on 'Security of supply'. Experts discussed challenges in patient care and the importance of cooperation in Specialty Pharma sector

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
BRIEF

published on 06/20/2024 at 10:07, 9 months 23 days ago

Transfert réussi des actions Medios AG à Luxempart SA

Investissement Medios AG Vente D'actions Pharmacie Spécialisée Luxempart SA
BRIEF

published on 06/20/2024 at 10:07, 9 months 23 days ago

Successful Transfer of Medios AG Shares to Luxempart S.A.

Investment Medios AG Share Sale Specialty Pharma Luxempart S.A.
PRESS RELEASE

published on 06/20/2024 at 10:02, 9 months 23 days ago

Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
Medios AG founder Manfred Schneider sells 14.9% of shares to Luxempart S.A., a Luxembourg investment company, marking a turning point in Medios' growth strategy

Investment Medios AG Specialty Pharma Luxempart S.A. Manfred Schneider
BRIEF

published on 06/07/2024 at 10:33, 10 months 6 days ago

Hauck & Aufhäuser lance la couverture de Medios AG avec une recommandation d'achat et un objectif de prix de 23,00 €

Medios AG Recommandation D'achat Pharmacie Spécialisée Hauck & Aufhäuser Objectif De Prix 23,00 €
BRIEF

published on 06/07/2024 at 10:33, 10 months 6 days ago

Hauck & Aufhäuser Initiates Coverage of Medios AG with Buy Recommendation and €23.00 Price Target

Buy Recommendation Medios AG Specialty Pharma Hauck & Aufhäuser Price Target €23.00
PRESS RELEASE

published on 06/07/2024 at 10:28, 10 months 6 days ago

Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
Hauck & Aufhäuser initiates coverage of Medios AG with buy recommendation and €23.00 price target, a 55% upside potential from Xetra closing price on June 5, 2024. Medios AG, a leading Specialty Pharma provider in Europe, aims at expanding innovative therapies

Buy Recommendation Medios AG Price Target Specialty Pharma Hauck & Aufhäuser

Accesswire

Published on 04/12/2025 at 15:45, 22 hours 57 minutes ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 12 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 14 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 1 day 14 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 1 day 14 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 1 day 16 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 1 day 20 hours ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 1 day 20 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 1 day 20 hours ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 1 day 20 hours ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 1 day 20 hours ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 1 day 20 hours ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 1 day 20 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 1 day 20 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 1 day 20 hours ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE